Navigation Links
WellPoint Receives Seven eHealthcare Leadership Awards
Date:1/8/2009

INDIANAPOLIS, Jan. 8 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE: WLP) has been honored with seven eHealthcare Leadership Awards for its, and its affiliated health plans', outstanding Web sites. The company's Careers at WellPoint site was honored with a Silver Award for Best Employee Recruitment site and the WellPoint Foundation's Web site received a Gold Award for Best Site Design. The Anthem.com site earned a Platinum Award for Best Healthcare Content for its MyHealth@Anthem demo; its OpenRoad site received a Gold Award for Best Site Design; and its Tonik site earned a Distinction Award for Best Site Design. UniCare.com also received two awards: a Gold Award for Best Overall Internet Site and a Silver Award for Best Healthcare Content.

The eHealthcare Leadership Awards recognize the best sites in the health care industry. These Web sites were chosen based on the quality of their Web content, interactive features, business integration, ease of navigation, and user experience. Strategic Health Care Communications, the publishers of eHealthcare Strategy & Trends and Strategic Health Care Marketing, sponsors the annual awards program. The program attracted more than 1,100 entries.

"We're proud of this recognition because we believe that well-designed Web sites can help consumers quickly find the information they need to make better health care decisions," said Chad Pomeroy, vice president, Innovation and eBusiness, for WellPoint. "We'll continue to create online tools and services that help our customers manage their health online and add value to their experiences with us."

This leading awards program exclusively recognizes the very best Web sites of health care providers, health plans, health care associations, online health companies, pharmaceutical/medical equipment firms, suppliers, other
'/>"/>

SOURCE WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. WellPoint Announces Appearance at Upcoming Conference
2. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
3. Healthbase Collaborates with WellPoint to Bring Affordable Medical Tourism Solutions
4. WellPoint to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 28, 2009
5. WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information
6. Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices
7. WellPoint Associates Pledge Record Amount to Community Organizations in 2009
8. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
9. Dr. Charles Kennedy, Vice President of Health Information Technology for WellPoint, Inc., to Present Today at The 4th Annual World Healthcare Innovation and Technology Congress (WHIT v.4.0)
10. WellPoint Announces Second Annual Innovation Event
11. WellPoint Congratulates President-Elect Barack Obama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...t kit called DrugConfirm™ ,is the ideal drug... and accurate instant drug test. Developed by Biot...ek, innovative design and incorporates new Push Bu...y priced compared to the other urine cup products ... San Diego (Vocus) – A n...
(Date:7/3/2009)...home medical services provider specializing in inf...ervices, is expanding. Two new pharmacies in Roche...sion therapy and one in oral medication, a new pro... Clinton, NY (PRWEB) June 22, 2009 -- Ups...pecializing in infusion, specialty medication, res...
(Date:7/2/2009)...swire/ -- Acetaminophen is an ingredient found in ...o help relieve pain and reduce fever. Many people...nd prescription brand names, Vicodin and Percocet....June 30, 2009 to address liver related injuries du...d 20-17 to urge the FDA to put a ban on Vicodin an...
(Date:7/2/2009)..., expert says , , THURSDAY, July 2 (Heal... species of wildlife, which need to be protected t...ancer is one of the leading health concerns for hu... deaths. But we now understand that cancer can kil...se McAloose, chief pathologist for the Wildlife Co...
Breaking Medicine News(10 mins):Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Cancer Endangers Some Wildlife Species 2
...s have identified the receptor pathway used by est...morrhage//. The related report by Hsieh et al, “G ...se A pathway is critical in nongenomic effects of ...-hemorrhage,” appears in the April issue of The Am...
...proximately 20% of children with Acute Lymphoblast...ir disease following treatment//. Of these, most w...t these relapses were due to small numbers of cell...ent administered to the patient," said Prof Norris...
...s no additional effect when given to depressed peo... mood stabilizer//, according to a recent study. ...e Systematic Treatment Enhancement Program for Bip...on clinical trial funded by the National Institute...
...ople whose diets contain dramatically more of one ...y be at greater risk// for both clinical depressio...published online this week in the journal Psychoso...to balance out our intake of omega-6 and omega-3 f...
Other Medicine News:Health News:Estrogen Protects Liver After Traumatic Injury 2Health News:Antidepressant Medication Has No Effect on Bipolar Patients 2Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 2Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 3
(Date:6/30/2009)... Pa., June 30 Cephalon, ... submitted a supplemental New Drug Application (sN... requesting approval of NUVIGIL(R) (armodafinil) T...ulness in patients with excessive sleepiness assoc...nd travel. Jet lag disorder is an acute condition...
(Date:6/29/2009)...tive Study Seeks to Assess RSV Burden in Outpatien...ommitment to Pediatric Research , , GAITHERSB...ues to advance its commitment to pediatric researc...onal prospective study designed to assess the burd...erm infants 32-to-35 weeks gestational age (GA) in...
(Date:6/29/2009)...arma Targets for Novel Biotherapeutics Based On Na...O, June 29 Pangu BioPharma, a subs...d the filing of its third patent application on pr...A synthetases. Although tRNA synthetases are univ...s machinery found in all organisms, human syntheta...
(Date:6/28/2009)...MAMEDE DO CORONADO, Portugal, June 29 /PRNewswire/...ed that add-on treatment with the novel,once-dai...tate; ESL) resulted,in a marked and sustained dec..., Results from the one-year extension of a ...ere presented at the International Congress for Ep...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Daiichi Sankyo Inc Announces Three Studies of Oral Factor Xa Inhibitor DU 176b Accepted for the 50th Annual Meeting of the American Society of Hemat 31007 1Daiichi Sankyo Inc Announces Three Studies of Oral Factor Xa Inhibitor DU 176b Accepted for the 50th Annual Meeting of the American Society of Hemat 31007 2Daiichi Sankyo Inc Announces Three Studies of Oral Factor Xa Inhibitor DU 176b Accepted for the 50th Annual Meeting of the American Society of Hemat 31007 3eResearchTechnology Inc to Present at the Piper Jaffray Health Care Conference on December 2 2008 9454 1eResearchTechnology Inc to Present at the Piper Jaffray Health Care Conference on December 2 2008 9454 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 1Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 4 DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale Up for New Bio based Product 9451 1 DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale Up for New Bio based Product 9451 2
Grooved roller, on which knife oscillates.
Disposable. For use with the N4086.
30 mm button end blade. Flat handle.
5 mm small, sharp, protected blade. Angled at 105 degrees. Flat handle. Designated most popular model or size.
Medicine Products: